Analysis of tumor mutational burden: correlation of five large gene panels with whole exome sequencing
Abstract Outcome of immune checkpoint inhibition in cancer can be predicted by measuring PDL1 expression of tumor cells. Search for additional biomarkers led to tumor mutational burden (TMB) as surrogate marker for neoantigens presented. While TMB was previously determined via whole exome sequencing...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/9ffba0af5f5c4416968c0b58a4842a72 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|